Tommaso Innocenti

MD, PhD
Gastroenterologist, endoscopist, IBD specialist @AOUCareggi
Assistant Professor of Gastroenterology @UNI_FIRENZE

[Tommaso Innocenti @IBD_Tom]

✨Happy 2026!🩺
Starting the new year with a minireview just published in #COPHAR 🥼📘
We discuss the shift from transmural healing to ultrasound remission as a new potential, pragmatic treatment target in IBD. #IBD #Ultrasound #IUS #PrecisionMedicine

🔗https://t.co/8DHccVGXwQ

[The Lancet @TheLancet]

The rise of ultra-processed foods is damaging public health, fuelling chronic diseases worldwide, and deepening health inequalities.

Urgent, coordinated global action is needed to address the UPF challenge.

Find out more in an Editorial ➡️ https://t.co/6hBuTB5XCv

[InternationalBowelUS @BowelUltrasound]

We are off to a great start with Day 1 of the IBUS Regional Module 1 in Milan! 🙌🏻🇮🇹

Today was filled with inspiring lectures and engaging hands-on sessions - we are excited for Day 2 tomorrow!

[Federica Borrelli @FBorrelliMD]

My friend @Bealoquebea gave an AMAZING talk at the #AGGEI Congress on how social media can boost dissemination and how AI is reshaping our daily work as professionals & researchers — always with an eye on the (next) future! 🚀💡

@aggei_gastro

[Beatriz Gros @Bealoquebea]

One is left speechless seeing the future that’s already here
Thank you @MariettaIacucci for showing us what’s coming and what has already arrived and for your incredible work in the thrilling field of prediction in IBD

@aggei_gastro

[Tommaso Innocenti @IBD_Tom]

@GabrieleDragoni @FCaprioli46756 @alearmuzzi @tommasoparigi @marie_truyens

[Tommaso Innocenti @IBD_Tom]

📣💊#JAKi failure in #UC? It’s not game over!

📊48% 12w-steroid-free remission
📆72% treatment persistence
💪 Better outcomes after secondary (vs primary) failure
🧘‍♂️ Safe profile, no major CV/thrombo events

Check the largest JAKi cycling study so far! 🔗 https://t.co/B7p5zmoA1o

[Maria Wei @mmmariawei]

📢Call for Papers!

🚀Special Issue:
Personalized Management of Inflammatory Bowel Diseases

👨‍💻Guest Editor: Dr. Tommaso Innocenti @IBD_Tom
⏳ Deadline: 30 August 2026
📌Submit now: https://t.co/XAUEBuEouC

Welcome Your Valuable Contributions!
@MDPIOpenAccess
@JPM_MDPI
#mdpijpm

[Mariangela Allocca @MariangelaAllo3]

Excited to announce our latest consensus paper.
This collaborative effort provides guidance on how to integrate intestinal ultrasound as an objective and reproducible endpoint in IBD trials.

[Beatriz Gros @Bealoquebea]

JAKi review of their use and position in IBD therapy

#UEGweek @my_ueg by Sebastian Zessig

[Rune Wilkens @RuneWilkens]

Once again a fantastic paper (detailed, honest, and well-performed) from the @GabrieleDragoni group with @IBD_Tom as first author - just published in @IBDJournals on #intestinalultrasound scores. Could easily have been published in @JCC_IBD

"Based on the results of our systematic review, the MUC and BUSS are fully validated IUS scores that showed ability in the early prediction of response to therapy in patients with UC and CD, respectively; therefore, they might be used in daily practice to define treatment strategies. On the other hand, the IBUS-SAS has the highest number of validation studies in both CD and UC, and its 0 to 100 scale might be more useful in detecting minimal changes for the rigorous application in randomized clinical trials. Based on the results of our systematic review, we then propose a flowchart for IUS scores implementation into treat-to-target strategies (Figure 3)."

https://t.co/uiuM8Retba

@BowelUltrasound @iuschris @michaeldolinger @novakkerri @iUSCAN @GENIUS_health1 @vipuljairath

[Tommaso Innocenti @IBD_Tom]

@GabrieleDragoni @LScarallo

[Tommaso Innocenti @IBD_Tom]

📢 New paper out!
We systematically reviewed all #IUS scores for #IBD (CD & UC) and their validation studies.
🔎 23 scores identified
📌 Most vs endoscopy
✅ Only few validated in multiple cohorts

Keep on using IUS #scores for standardizing IBD care!

➡️https://t.co/XW44oMQRNV

[Vipul Jairath MBChB DPhil @vipuljairath]

An International Consensus on Appropriate Management of Corticosteroids in Clinical Trials in Inflammatory Bowel Disease. Much needed effort to standardize the approach to steroids in trials lead by ⁦@ChrisMa_YYC⁩ with global contributions! https://t.co/2uAR3EBAxp

[Tommaso Innocenti @IBD_Tom]

@BowelUltrasound @GabrieleDragoni

[Tommaso Innocenti @IBD_Tom]

🚀 New research out now! 🚀

Can #IBUSSAS improve the assessment of #UC activity? 🔬🩺

Our latest study dives into this #IUS score, comparing it with other existing scores for a more precise evaluation of colonic disease activity.

🔗 Read more: https://t.co/Lr9B2PSHFZ

[José Antonio Olmos @joseantonio83]

New IBD classification. Florence classification @doc_ibd @IBDCedarsSinai #ECCO2025